adrenergic receptor, alpha 2a |
TEGAFUR |
Imidazoline I2, Central |
-17% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
TEGAFUR |
Imidazoline I2, Central |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
PIPERILATE ETHOBROMIDE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
VINBLASTINE |
Serotonin Transporter |
-17% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
LEAD(IV) ACETATE |
Histamine H2 |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
PROCARBAZINE |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
PROCARBAZINE |
Glycine, Strychnine-Sensitive |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
PROCAINAMIDE |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
PROCAINAMIDE |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
bradykinin receptor, beta 2 |
PROMETHAZINE |
Bradykinin B2 |
-17% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
PROMETHAZINE |
Bradykinin B2 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
PHENYTOIN |
Serotonin 5-HT2A |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
PROMETHAZINE |
CYP450-2C9 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
PROMETHAZINE |
CYP450-2C9 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, iota |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, beta 1 |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, delta |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
ACECLOFENAC |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
ACECLOFENAC |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
ACECLOFENAC |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
NORETHINDRONE |
Leukotriene C4 Synthetase |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
NORETHINDRONE |
Leukotriene C4 Synthetase |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
EPALRESTAT |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
EPALRESTAT |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
EPALRESTAT |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
EPALRESTAT |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
angiotensin II receptor, type 2 |
SODIUM ARSENITE |
Angiotensin AT2 |
-17% |
NoneNone |
NoneNone |
View
|
insulin receptor |
OXICONAZOLE |
Insulin |
-17% |
NoneNone |
NoneNone |
View
|
insulin receptor |
OXICONAZOLE |
Insulin |
-17% |
NoneNone |
NoneNone |
View
|
interleukin 1 receptor, type I |
NORETHINDRONE |
Interleukin IL-1 alpha |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
ONDANSETRON |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
ONDANSETRON |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
ONDANSETRON |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
ONDANSETRON |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
ONDANSETRON |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
ONDANSETRON |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
TROXIPIDE |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
TROXIPIDE |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
TROXIPIDE |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
TROXIPIDE |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
TROXIPIDE |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 1 |
OXYBUTYNIN |
Tachykinin NK1 |
-17% |
NoneNone |
NoneNone |
View
|
endothelin receptor type A |
ACYCLOVIR |
Endothelin ETA |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
NETILMICIN |
Vascular Endothelinal Growth Factor (VEGF) |
-17% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
NETILMICIN |
Vascular Endothelinal Growth Factor (VEGF) |
-17% |
NoneNone |
NoneNone |
View
|
epidermal growth factor receptor |
YOHIMBINE |
Protein Tyrosine Kinase, EGF Receptor |
-17% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
ANTIPYRINE |
Adrenergic alpha2A |
-17% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
ANTIPYRINE |
Dopamine D3 |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
TEMAFLOXACIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
TEMAFLOXACIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
TEMAFLOXACIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
TEMAFLOXACIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
TEMAFLOXACIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
TEMAFLOXACIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1B |
DIGITOXIN |
Serotonin 5-HT1B |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
BISACODYL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
BISACODYL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
BISACODYL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
BISACODYL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
BISACODYL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
BISACODYL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
melanocortin 3 receptor |
TRIAMCINOLONE ACETONIDE |
Melanocortin MC3 |
-17% |
NoneNone |
NoneNone |
View
|
melanocortin 3 receptor |
TRIAMCINOLONE ACETONIDE |
Melanocortin MC3 |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
HYDROCORTISONE |
CYP450-1A2 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
DIFLUNISAL |
Muscarinic M1 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
CYTARABINE |
Serotonin 5-HT4 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
CYTARABINE |
Serotonin 5-HT4 |
-17% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
ERYTHROMYCIN |
Vasoactive Intestinal Peptide VIP1 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
SULBACTAM |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
opioid receptor, delta 1 |
SULFANILAMIDE |
Opiate delta |
-17% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
SULFABENZAMIDE |
Protein Tyrosine Kinase, HER2 Receptor |
-17% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
SULFABENZAMIDE |
Protein Tyrosine Kinase, HER2 Receptor |
-17% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
BLEOMYCIN A2 |
Dopamine D3 |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
NEOMYCIN |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
NEOMYCIN |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
NEOMYCIN |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
NEOMYCIN |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
NEOMYCIN |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
AMINOPHYLLINE |
Purinergic P2X |
-17% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
AMINOPHYLLINE |
Purinergic P2X |
-17% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
AMINOPHYLLINE |
Purinergic P2X |
-17% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
RIFAPENTINE |
Cannabinoid CB1 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
MEDROXYPROGESTERONE ACETATE |
Serotonin 5-HT2B |
-17% |
NoneNone |
NoneNone |
View
|
epidermal growth factor receptor |
ACEMETACIN |
Protein Tyrosine Kinase, EGF Receptor |
-17% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
ACEMETACIN |
Phosphodiesterase PDE3 |
-17% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
ACEMETACIN |
Phosphodiesterase PDE3 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
KITASAMYCIN |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
KITASAMYCIN |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
ETHISTERONE |
Protein Serine/Threonine Kinase, ERK2 |
-17% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
ETHISTERONE |
Protein Serine/Threonine Kinase, ERK2 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
ANDROSTERONE |
Serotonin 5-HT2B |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
DIPHENIDOL |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
DIPHENIDOL |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
DIPHENIDOL |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
DIPHENIDOL |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
DIPHENIDOL |
Glutamate, Kainate |
-17% |
NoneNone |
NoneNone |
View
|
estrogen receptor 1 |
AMPHOTERICIN B |
Estrogen ERalpha |
-17% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
ANDROSTERONE |
Adrenergic alpha2B |
-17% |
NoneNone |
NoneNone |
View
|
estrogen receptor 1 |
AMPHOTERICIN B |
Estrogen ERalpha |
-17% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
ETHISTERONE |
Chemokine CXCR1(IL-8A) |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
DOXYCYCLINE |
Serotonin 5-HT2A |
-17% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 1 |
FERULIC ACID |
Tachykinin NK1 |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
METHYLERGONOVINE |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
METHYLERGONOVINE |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
METHYLERGONOVINE |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
METHYLERGONOVINE |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
METHYLERGONOVINE |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
METHYLERGONOVINE |
Nicotinic Acetylcholine, Central |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
ASCORBIC ACID |
Serotonin 5-HT1A |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
GRAMICIDIN |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
GRAMICIDIN |
Serotonin 5-HT3 |
-17% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
LISINOPRIL |
Progesterone |
-17% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
LISINOPRIL |
Progesterone |
-17% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
DIGITONIN |
beta-Lactamase |
-17% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
ABAMECTIN |
Protein Serine/Threonine Kinase, ERK2 |
-17% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
ABAMECTIN |
Protein Serine/Threonine Kinase, ERK2 |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
METHYLDOPA |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
METHYLDOPA |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
METHYLDOPA |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
METHYLDOPA |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
METHYLDOPA |
Neuropeptide Y2 |
-17% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
METHYLDOPA |
Neuropeptide Y2 |
-17% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
COBALT(II) ACETYLACETONATE |
Monoamine Oxidase MAOA |
-17% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
COBALT(II) ACETYLACETONATE |
Monoamine Oxidase MAOA |
-17% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
VALSARTAN |
Calcitonin |
-17% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
CORTISONE |
Cannabinoid CB1 |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
LISINOPRIL |
Serotonin 5-HT4 |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
IMATINIB |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
ERGOCALCIFEROL |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
ERGOCALCIFEROL |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
ERGOCALCIFEROL |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
ERGOCALCIFEROL |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
SAFROLE |
Cyclooxygenase COX-2 |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
SAFROLE |
Cyclooxygenase COX-2 |
-17% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 2 |
EPINEPHRINE |
Chemokine CCR2B |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
TOLPERISONE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
TOLPERISONE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
TOLPERISONE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
TOLPERISONE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
OXYTETRACYCLINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
DEFERIPRONE |
Cyclooxygenase COX-2 |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
DEFERIPRONE |
Cyclooxygenase COX-2 |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
SULFABENZAMIDE |
CYP450-1A2 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
DEFERIPRONE |
GABAA, Benzodiazepine, Central |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
DEFERIPRONE |
GABAA, Benzodiazepine, Central |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
DEFERIPRONE |
GABAA, Benzodiazepine, Central |
-17% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
DEFERIPRONE |
GABAA, Benzodiazepine, Central |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
DEFERIPRONE |
GABAA, Benzodiazepine, Central |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
DEFERIPRONE |
GABAA, Benzodiazepine, Central |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
DEFERIPRONE |
GABAA, Benzodiazepine, Central |
-17% |
NoneNone |
NoneNone |
View
|